However, expression of ESRRA was unaltered in skeletal muscle of individuals with NGT or type 2 diabetes, suggesting that reduction in PGC-1α is sufficient to impair BCAA expression or, alternatively, the PGC-1α–ERRα interaction is compromised in type 2 diabetes. The gene discussed is ESRRA; the disease is type 2 diabetes mellitus.